TOPAZ-1: a new standard of care for advanced biliary tract cancers?

Immunotherapy. 2023 May;15(7):473-476. doi: 10.2217/imt-2022-0269. Epub 2023 Mar 23.

Authors

Matthew I Ebia¹, Kamya Sankar^{1

2}, Arsen Osipov^{1

2}, Andrew E Hendifar^{1

2}, Jun Gong^{1

2}

Affiliations

¹ Department of Medicine, Division of Hematology & Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
² Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA 90048, USA.

PMID: 36950948
DOI: 10.2217/imt-2022-0269

No abstract available

Keywords: biliary tract cancer; cancer survival; checkpoint inhibitors; chemotherapy; cholangiocarcinoma.

Publication types

Editorial

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Bile Duct Neoplasms*
Biliary Tract Neoplasms*
Humans
Standard of Care